Sionna Therapeutics Alternatives & Competitors
12 companies similar to Sionna Therapeutics — Dedicated to delivering therapies that could be transformational for people livi...
Companies similar to Sionna Therapeutics
Enterprise Therapeutics
Dedicated to the development of novel therapies to improve the lives of patients with resp...
Brighton, United Kingdom
Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...
Watertown, United States
Kezar Life Sciences
Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic diso...
South San Francisco, Unit...
Sharp Therapeutics
Developing small molecule drugs for genetic diseases..
Pittsburgh, United States
Rival Readout
Competing with Sionna Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Sunnyvale, United States
Spinogenix, Inc.
Developing a new class of therapeutics for neurodegenerative and psychiatric diseases
Los Angeles, United State...
RareCan
RareCan aims to accelerate research and ultimately improve treatments and outcomes for peo...
United Kingdom
Thetis Pharmaceuticals
Resolving disease without compromising host defense
Essex, United States
ProQR Therapeutics
Advancing our proprietary Axiomer™ RNA-editing platform technology
Leiden, The Netherlands
Synendos Therapeutics AG
Breakthrough safe and effective therapies for neuropsychiatric disorders
Basel, Switzerland
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Nephrogen
Curative gene therapies for kidney diseases
New York, United States
About Sionna Therapeutics
Sionna Therapeutics, founded in 2019 and headquartered in the United States, is a burgeoning force within the Biotechnology and Pharmaceutical industries. Guided by its slogan, "Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis," the company is spearheading innovati...
Development of novel cystic fibrosis treatments, Stabilization of CFTR's Nucleotide-Binding Domain 1, Engineering small molecules for F508del mutation, Complementary CFTR modulator development
Cystic Fibrosis Patients, Healthcare Providers, Research Institutions
Cystic Fibrosis, Life Sciences, Genetic Mutations, Therapies, Small Molecules, CFTR Function, Research, Drug Development
B2B, B2B2C
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Sionna Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Sionna Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
